These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21468258)

  • 21. Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer.
    Lin CC; Hsu CH; Cheng JC; Wang HP; Lee JM; Yeh KH; Yang CH; Lin JT; Cheng AL; Lee YC
    Ann Oncol; 2007 Jan; 18(1):93-98. PubMed ID: 17028244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
    Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of radiation schedule and chemotherapy duration in definitive chemoradiotherapy regimen for esophageal cancer.
    Di Fiore F; Lecleire S; Galais MP; Rigal O; Vié B; David I; Hamidou H; Paillot B; Jacob JH; Michel P
    Gastroenterol Clin Biol; 2006; 30(6-7):845-51. PubMed ID: 16885868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
    Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
    Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303).
    Shinoda M; Ando N; Kato K; Ishikura S; Kato H; Tsubosa Y; Minashi K; Okabe H; Kimura Y; Kawano T; Kosugi S; Toh Y; Nakamura K; Fukuda H;
    Cancer Sci; 2015 Apr; 106(4):407-12. PubMed ID: 25640628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of Survival in Esophageal Squamous Cell Carcinoma with Pathologic Major Response after Neoadjuvant Chemoradiation Therapy and Surgery: The Impact of Chemotherapy Protocols.
    Li CY; Huang PM; Chu PY; Chen PM; Lin MW; Kuo SW; Lee JM
    Biomed Res Int; 2016; 2016():6423297. PubMed ID: 27777949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility and efficacy of concurrent chemoradiotherapy in elderly patients with esophageal squamous cell carcinoma: a respective study of 116 cases from a single institution.
    Li X; Zhao LJ; Liu NB; Zhang WC; Pang QS; Wang P; Yuan ZY
    Asian Pac J Cancer Prev; 2015; 16(4):1463-9. PubMed ID: 25743816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study.
    Xu Y; Zheng Y; Sun X; Yu X; Gu J; Wu W; Zhang G; Hu J; Sun W; Mao W
    Oncotarget; 2015 Nov; 6(35):38429-39. PubMed ID: 26392415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy.
    Pao TH; Chang WL; Chiang NJ; Chang JS; Lin CY; Lai WW; Tseng YL; Yen YT; Chung TJ; Lin FC
    Radiat Oncol; 2020 Sep; 15(1):221. PubMed ID: 32962730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: Experience of two centers.
    Chen F; Luo H; Xing L; Liang N; Xie J; Zhang J
    Thorac Cancer; 2018 Jan; 9(1):59-65. PubMed ID: 29024498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I study of concurrent selective lymph node late-course accelerated hyperfractionated radiotherapy and S-1 plus cisplatin for locally advanced oesophageal squamous cell carcinoma.
    Li M; Fu C; Zhang W; Huang W; Wang Z; Zhou T; Lin H; Li B
    Br J Radiol; 2016; 89(1060):20150476. PubMed ID: 26891913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors predictive of tumor recurrence and survival after initial complete response of esophageal squamous cell carcinoma to definitive chemoradiotherapy.
    Ishihara R; Yamamoto S; Iishi H; Takeuchi Y; Sugimoto N; Higashino K; Uedo N; Tatsuta M; Yano M; Imai A; Nishiyama K
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):123-9. PubMed ID: 19386426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weekly Chemotherapy of 5-Fluorouracil plus Cisplatin Concurrent with Radiotherapy for Esophageal Squamous Cell Carcinoma Patients with Postoperative Locoregional Recurrence: Results from a Phase II Study.
    Chen B; Li Q; Li Q; Qiu B; Xi M; Liu M; Hu Y; Zhu Y
    Oncologist; 2020 Apr; 25(4):308-e625. PubMed ID: 31880371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VEGF G-1154A is predictive of severe acute toxicities during chemoradiotherapy for esophageal squamous cell carcinoma in Japanese patients.
    Sakaeda T; Yamamori M; Kuwahara A; Hiroe S; Nakamura T; Okumura K; Okuno T; Miki I; Chayahara N; Okamura N; Tamura T
    Ther Drug Monit; 2008 Aug; 30(4):497-503. PubMed ID: 18641541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
    Hsu CH; Yeh KH; Lui LT; Lee YC; Bu CF; Wang HP; Lin JT; Cheng AL
    Anticancer Res; 1999; 19(5C):4463-7. PubMed ID: 10650793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical results of definitive chemoradiotherapy for patients with synchronous head and neck squamous cell carcinoma and esophageal cancer.
    Shinoto M; Shioyama Y; Sasaki T; Nakamura K; Ohura H; Toh Y; Higaki Y; Yamaguchi T; Ohnishi K; Atsumi K; Hirata H; Honda H
    Am J Clin Oncol; 2011 Aug; 34(4):362-6. PubMed ID: 20686402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
    Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
    Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor length assessed by miniprobe endosonography can predict the survival of the advanced esophageal squamous cell carcinoma with stricture receiving concurrent chemoradiation.
    Chang WL; Lin FC; Yen CJ; Cheng H; Lai WW; Yang HB; Sheu BS
    Dis Esophagus; 2011 Nov; 24(8):590-5. PubMed ID: 21539673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study.
    Lyu J; Li T; Wang Q; Li F; Diao P; Liu L; Li C; Lang J
    Radiat Oncol; 2018 Nov; 13(1):233. PubMed ID: 30477531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Docetaxel and cisplatin concurrent with radiotherapy versus 5-fluorouracil and cisplatin concurrent with radiotherapy in treatment for locally advanced oesophageal squamous cell carcinoma: a randomized clinical study.
    Zhao T; Chen H; Zhang T
    Med Oncol; 2012 Dec; 29(5):3017-23. PubMed ID: 22476809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.